Robert G. Shawah
Chief Financial Officer · Acurx Pharmaceuticals, Inc.
Individual
- 2026
- Apr 22, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Robert G. Shawah's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- RA CAPITAL MANAGEMENT, L.P. - $40.00M in BCAX purchases and sales in the last 12 months
- Sanj K. Patel - $39.43M in KNSA purchases and sales in the last 12 months
- Hellman & Friedman Capital Partners X (Parallel), L.P. - $2.65B in MDLN purchases and sales in the last 12 months
- BX Mozart ML-2 Holdco L.P. - $2.35B in MDLN purchases and sales in the last 12 months
- BCP 8 Holdings Mozart Manager L.L.C. - $2.35B in MDLN purchases and sales in the last 12 months
- LILLY ENDOWMENT INC - $2.23B in LLY purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Robert G. Shawah?
Robert G. Shawah is a corporate insider, tracked as Chief Financial Officer of Acurx Pharmaceuticals, Inc. (ACXP). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Robert G. Shawah last file a Form 4?
The only primary Form 4 on record is dated 22 April 2026.